Webinars

Regulatory Briefing: Marketplace Integrity and Affordability Proposed Rule

  • Wednesday, Mar. 26, 2025 | 12pm ET
Webinars

Understanding the Devastating Impact of C3G and Primary IC-MPGN

  • Tuesday, Mar. 25, 2025 | 2–3pm ET
Webinars

Bridging the Gap: Development of Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers through the AMCP RWE Initiative

  • Thursday, Mar. 6, 2025 | 2–3pm ET
Webinars

Prademagene Zamikeracel (pz-cel) Pre-Approval Information Exchange

  • Tuesday, Mar. 4, 2025 | 2–3pm ET
Webinars

Potential antithrombin therapy for patients with hemophilia A and B

  • Wednesday, Mar. 12, 2025 | 2–3pm ET
Webinars

UGN-102 Pre-Approval Information Exchange (PIE) Presentation

  • Wednesday, Mar. 26, 2025 | 2–3pm ET
Webinars

AMCP Market Insights: Managed Care Approaches to Address Unmet Patient Needs in Multiple Sclerosis (MS)

  • Wednesday, Mar. 5, 2025 | 2-3pm ET
Webinars

A Closer Look at Psoriasis, Beyond the Skin

  • Thursday, Mar. 20, 2025 | 2–3pm ET
Webinars

Policy Outlook 2025: The Trump Administration and the 119th Congress

  • Wednesday, Jan. 29, 2025 | 2–3pm ET
Webinars

The Missing PIEce: Best Practices for Implementing Pre-Approval Information Exchange (PIE) in a Payer Communication Plan

  • Friday, Mar. 14, 2025 | 2-3pm ET
Webinars

Evolution of the Standards of Care in Atopic Dermatitis

  • Tuesday, Feb. 18, 2025 | 2–3pm ET
Webinars

Rezurock® (belumosudil) Clinical Efficacy and Safety on cGVHD Patients

  • Thursday, Feb. 27, 2025 | 2-3pm ET